AW
UTHR icon

Avion Wealth’s United Therapeutics UTHR Stock Holding History

Avion Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4K Hold
9
– – ﹤0.01% 886
2026
Q1 		$5K Hold
9
– – ﹤0.01% 687
2025
Q4 		$4K Sell
9
-4
-31% -$1.86K ﹤0.01% 746
2025
Q3 		$5K Sell
13
-69
-84% -$23.2K ﹤0.01% 669
2025
Q2 		$23K Buy
82
+73
+811% +$21.8K 0.01% 297
2025
Q1 		$3K Hold
9
– – ﹤0.01% 676
2024
Q4 		$3K Buy
9
+2
+29% +$735 ﹤0.01% 673
2024
Q3 		$2K Buy
7
+1
+17% +$338 ﹤0.01% 727
2024
Q2 		$1K Sell
6
-2
-25% -$529 ﹤0.01% 832
2024
Q1 		$2K Hold
8
– – ﹤0.01% 789
2023
Q4 		$2K Hold
8
– – ﹤0.01% 635
2023
Q3 		$1K Buy
8
+2
+33% +$461 ﹤0.01% 747
2023
Q2 		$0 Buy
+6
New +$1.33K ﹤0.01% 1046

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Avion Wealth's UTHR Position: Q2 2026 in Review

Avion Wealth held its United Therapeutics (UTHR) position steady in Q2 2026 at 9 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #886.

Avion Wealth first reported a position in UTHR in Q2 2023 and has held it in 13 quarters since. The position peaked at $23K in Q2 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Avion Wealth held 9 shares of United Therapeutics worth $4K as of Q2 2026.
  • Avion Wealth left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #886 holding.
  • Avion Wealth first reported a position in United Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Avion Wealth's United Therapeutics position peaked at $23K in Q2 2025.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.